Your Health, We Care

Home >Drug List>Repotrectinib>Indications of Repotrectinib

Repotrectinib(LuciRepo)

Release date: 2026-01-05 15:39:38     Recommended: 336

Adult patients with locally advanced or metastatic ROS1 positive non-small cell lung cancer (NSCLC).